IMMUNOPLANT for Newly Diagnosed Multiple Myeloma

Clinical trial NCT06376526 · RECRUITING

Trial details

NCT number: NCT06376526
Sponsor: Dickran Kazandjian, MD
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2024-08-21
Primary completion: 2027-08-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.